AzTrials
AzTrials

Condition

Atrial Fibrillation Clinical Trials

Studies of atrial fibrillation, matched by condition name and medical subject headings. Start with those open to enrolment.

4,056 registered studies

In numbers

Open to volunteers
801
Active
982
With results posted
531
All registered
4,056

Open to volunteers: recruiting, not yet recruiting or enrolling by invitation. Active adds studies under way that have stopped recruiting.

Open to volunteers

All 801
  • Atrial Fibrillation, Persistent Atrial Fibrillation

    Feasibility Study of the FARAFLEX Mapping and PFA System

    • Recruiting
    • Age: 18 years and older
    • Medical device

    The objective of this feasibility study is to evaluate the safety and effectiveness of the FARAFLEX mapping and pulsed field ablation (PFA) catheter, a novel catheter in treating persistent atrial fibrillation (PersAF) or…

    Conditions
    Atrial Fibrillation, Persistent Atrial Fibrillation, Paroxysmal AF
    Trial name
    ELEVATE-PF (NCT06510556)
    Testing
    FARAFLEX Ablation Treatment, ELEVATE-COR Sub-study
    Where
    4 sites in Belgium, Croatia and 2 more
    Volunteers
    250 people
    Sponsor
    Boston Scientific Corporation
    Can I take part? ELEVATE-PF
  • Paroxysmal Atrial Fibrillation, Persistent Atrial Fibrillation

    Evaluation of Novel Waveforms Delivered Using the FARAPULSE™ PFA System

    • Recruiting
    • Age: 18 years and older
    • Medical device

    This is a multicenter, prospective, single-arm, feasibility study to evaluate the safety and effectiveness of the waveforms being delivered using the FARAPULSE PFA System in patients with Paroxysmal Atrial Fibrillation (PAF) and…

    Trial name
    IMPULSE-EVO (NCT07444320)
    Testing
    FARAPULSE™ Pulsed Field Ablation (PFA) System
    Where
    4 sites in Croatia, Czechia and 2 more
    Volunteers
    200 people
    Sponsor
    Boston Scientific Corporation
    Can I take part? IMPULSE-EVO
  • Atrial Fibrillation (AF), Paroxysmal AF

    Comprehensive LEFt Atrial Appendage Occlusion With Rhythm Restoration

    • Recruiting
    • Age: 18 years and older
    • Medical device
    • Surgery or procedure

    The objective of this clinical investigation is to evaluate the feasibility, safety, and effectiveness of a concomitant procedure involving the Volt PFA System and Amulet 2 device in patients indicated for both AF ablation and…

    Conditions
    Atrial Fibrillation (AF), Paroxysmal AF, Persistent Atrial Fibrillation
    Trial name
    CLEAR (NCT07523620)
    Testing
    PVI Ablation, Left Atrial Appendage Occluder Implant
    Where
    16 sites in Belgium, Czechia and 8 more
    Volunteers
    240 people
    Sponsor
    Abbott Medical Devices
    Can I take part? CLEAR
  • Paroxysmal Atrial Fibrillation (PAF), Persistent Atrial Fibrillation

    Evaluation of the FARAFLEX Mapping and Pulsed Field Ablation System in Subjects With Atrial Fibrillation

    • Recruiting
    • Age: 18 years and older
    • Medical device

    The goal of this clinical trial is to learn if the FARAFLEX™ Mapping and pulsed field ablation (PFA) System can safely and effectively treat symptomatic, drug-refractory Paroxysmal atrial fibrillation (PAF) and Persistent atrial…

    Trial name
    FARADIGM (NCT07575269)
    Testing
    FARAFLEX Mapping and Pulsed Field Ablation (PFA) System
    Where
    13 sites in United States, Belgium and 2 more
    Volunteers
    571 people
    Sponsor
    Boston Scientific Corporation
    Can I take part? FARADIGM
  • Atrial Fibrillation (AF), Persistent Atrial Fibrillation (PersAF)

    A Global Randomized Trial Evaluating the FARAFLEX™ Mapping and Pulsed Field Ablation System With Electrographic Flow Mapping in Patients Undergoing Repeat Ablation for Atrial Fibrillation

    • Not yet recruiting
    • Age: 18 years and older
    • Medical device

    The goal of the ReDEFINE-AF Clinical Study is to evaluate the safety and effectiveness of the FARAFLEX™ Mapping and Pulsed Field Ablation System with electrographic flow mapping in subjects undergoing repeat ablation for atrial…

    Conditions
    Atrial Fibrillation (AF), Persistent Atrial Fibrillation (PersAF), Paroxysmal Atrial Fibrillation (PAF)
    Trial name
    ReDEFINE-AF (NCT07820930)
    Testing
    FARAFLEX Mapping and Pulsed Field Ablation System
    Volunteers
    650 people
    Sponsor
    Boston Scientific Corporation
    Can I take part? ReDEFINE-AF
  • Atrial Fibrillation (AF), Cerebral Vascular Accident (CVA)

    Pilot Study to Determine the Optimal Protocol for Preoperative Transcutaneous Vagal Neurostimulation

    • Not yet recruiting
    • Age: 18 years and older

    Post-operative atrial fibrillation (POAF) is a frequent complication of surgical aortic valve replacement, affecting 38 to 63% of patients, and increasing risks of stroke, heart failure, and long-term mortality.

    Conditions
    Atrial Fibrillation (AF), Cerebral Vascular Accident (CVA), Heart Failure, Myocardial Infarction (MI)
    Trial name
    VAGASTIMA-PILT (NCT07891390)
    Testing
    tVNS session on the left earlobe
    Where
    3 sites in France
    Volunteers
    64 people
    Sponsor
    Centre Hospitalier Universitaire de Saint Etienne
  • Atrial Fibrillation, Postoperative Atrial Fibrillation

    SGB for Prevention of Postop A-Fib After Cardiac SurgeryTrial

    • Not yet recruiting
    • Age: 18 years and older
    • Phase 3
    • Injection or infusion

    This research study is being conducted to determine whether a stellate ganglion block, a small injection in the neck that temporarily reduces sympathetic nervous system activity, can help reduce the risk of developing…

    Trial name
    NCT07893275
    Testing
    Stellate Ganglion Block Injection with 10 mL 0.5% Bupivacaine, Stellate Ganglion Block Injection with 10 mL Normal Saline
    Volunteers
    60 people
    Sponsor
    The Cleveland Clinic
    Can I take part? NCT07893275
  • Heart Failure, Coronary Heart Disease (CHD)

    Reliability of Multiple-Repetition-Maximum Tests in Patients With Cardiovascular Disease or Risk Factors

    • Recruiting
    • Age: 50 years and older
    • Observational study

    Exercise training is a cornerstone in the prevention and rehabilitation of cardiovascular disease. While research has primarily focused on endurance training, resistance training becomes more and more important.

    Conditions
    Heart Failure, Coronary Heart Disease (CHD), Atrial Fibrillation (AF), Diabetes Mellitus
    Trial name
    NCT06796582
    Where
    Germany
    Volunteers
    50 people
    Sponsor
    Technical University of Munich
    Can I take part? NCT06796582
  • Atrial Fibrillation, Atrial Flutter

    Anatomical Navigation for Guided Electrophysiology in AFL and AFib

    • Recruiting
    • Age: 18 years and older
    • Medical device

    The objective of the study is to collect data on the use of the VERAFEYE Anatomical Guidance System in adult patients indicated to undergo a catheter ablation procedure for the treatment of Atrial Flutter (AFL), paroxysmal AF…

    Conditions
    Atrial Fibrillation, Atrial Flutter, Atrial Arrhythmia
    Trial name
    ANGEL-AF (NCT07210151)
    Testing
    VERAFEYE Anatomic Guidance System
    Where
    4 sites in Croatia, Czechia and 1 more
    Volunteers
    50 people
    Sponsor
    LUMA Vision Ltd.
    Can I take part? ANGEL-AF
  • Atrial Fibrillation (AF)

    Assessment of Catheter Tissue Contact in PFA

    • Not yet recruiting
    • Age: 18 to 80 years
    • Medical device

    Pulmonary vein isolation remains the cornerstone of invasive treatment for atrial fibrlllation. Despite recent technological advances in the field of pulsed field ablation (PFA) pulmonary vein isolation durability and arrhythmia…

    Trial name
    ASSESS PFA (NCT07721948)
    Testing
    Electrode tissue contact assessment during pulsed field ablation
    Where
    Slovenia
    Volunteers
    60 people
    Sponsor
    University Medical Centre Ljubljana
    Can I take part? ASSESS PFA

Completed, with results posted

All –
  • Atrial Fibrillation, Atrial Flutter

    Colchicine For The Prevention Of Perioperative Atrial Fibrillation In Patients Undergoing Thoracic Surgery (COP-AF)

    • Completed
    • Age: 55 years and older
    • Phase 3
    • Pill or oral medicine
    • Results posted

    The prevention of perioperative atrial fibrillation (AF) and myocardial injury after non-cardiac surgery (MINS) has the potential to reduce mortality, stroke, and hospital stays in patients undergoing major thoracic surgery.

    Conditions
    Atrial Fibrillation, Atrial Flutter, Myocardial Injury After Non-Cardiac Surgery
    Trial name
    COP-AF (NCT03310125)
    Testing
    Active Colchicine
    Where
    46 sites in United States, Austria and 9 more
    Volunteers
    3,209 people
    Sponsor
    Population Health Research Institute
    Can I take part? COP-AF
  • Atrial Fibrillation, Patient Engagement

    Data-driven SDM to Reduce Symptom Burden in AF

    • Completed
    • Age: 18 years and older
    • Results posted

    This study is a single-group feasibility study evaluating decision aid visualizations which display common post-ablation symptom patterns as a tool for shared decision-making.

    Trial name
    NCT04993807
    Testing
    Shared decision-making tool
    Where
    2 sites in United States
    Volunteers
    75 people
    Sponsor
    Columbia University
    Can I take part? NCT04993807
  • Atrial Fibrillation

    Metformin as an Adjunctive Therapy to Catheter Ablation in Atrial Fibrillation

    • Completed
    • Age: 18 years and older
    • Phase 4
    • Pill or oral medicine
    • Medical device
    • Results posted

    This clinical trial is being done to determine if metformin, a drug which is normally used in diabetes, can reduce atrial fibrillation in patients who are having an ablation for atrial fibrillation (AF).

    Trial name
    NCT04625946
    Testing
    Metformin, Recommendations for lifestyle modification., AliveCor
    Where
    United States
    Volunteers
    117 people
    Sponsor
    University of Michigan
  • Atrial Fibrillation

    A Study For Treatment of Paroxysmal Atrial Fibrillation (PAF) With the OMNYPULSE Catheter and the TRUPULSE Generator

    • Completed
    • Age: 18 to 75 years
    • Medical device
    • Results posted

    The purpose of this study is to demonstrate safety and effectiveness of the ablation system (OMNYPULSE Bi-directional catheter and TRUPULSE generator) when used for isolation of the atrial pulmonary veins (PVs) in treatment of…

    Trial name
    Omny-IRE (NCT05971693)
    Testing
    OMNYPULSE Bi-Directional Catheter with TRUPULSE Generator
    Where
    13 sites in Belgium, Canada and 6 more
    Volunteers
    188 people
    Sponsor
    Biosense Webster, Inc.
    Can I take part? Omny-IRE
  • Atrial Fibrillation

    Evaluation of YouControl-AFib, a mHealth Application for Persons With Atrial Fibrillation

    • Completed
    • Age: 18 to 80 years
    • Medical device
    • Results posted

    This study is being done to establish the feasibility of performing a clinical trial using a mHealth application named YouControl-AFib designed to improve the cardiovascular health of persons with atrial fibrillation.

    Trial name
    NCT06575348
    Testing
    YouControl-A-Fib mHealth Application
    Where
    United States
    Volunteers
    51 people
    Sponsor
    University of Wisconsin, Madison
    Can I take part? NCT06575348

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in